X-ray tables, marked cards and the Mafia: How the FBI says poker games were rigged

A Basketball Hall of Famer. X-ray poker tables. The Mafia. They were all purportedly crucial to an alleged yearslong illegal poker rigging scheme that resulted in 31 federal indictments this week. The case focused on rigged poker games is one of two announced that allegedly involve prominent NBA figures. Investigators state that the scheme to … Read more

When Is Colleen Hoover’s ‘Regretting You’ Coming To Streaming?

Mason Thames and Mckenna Grace in “Regretting You.” Paramount Pictures Regretting You, the movie adaptation of Colleen Hoover’s novel starring Allison Williams, Mckenna Grace, Mason Thames and Dave Franco, is new in theaters. When will the romantic drama be available to stream at home? Directed by Josh Boone (The Fault in Our Stars), Regretting You … Read more

Premier League live updates: Matheus Cunha scores first Man United goal

Oct 25, 2025, 01:02 PM ET We’re back with another action-packed weekend of football across Europe! In the Premier League, Manchester United will be aiming to extend their two-game winning streak against Brighton & Hove Albion, and Liverpool host Brentford hoping to bounce back in the league after a commanding performance in the UEFA Champions … Read more

Avacta presents first preclinical data from dual payload

LONDON and PHILADELPHIA, Oct. 25, 2025 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, ‘Avacta’, ‘the Company’), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today announced the presentation of preclinical data demonstrating its novel first-in-class dual payload pre|CISION® technology (AVA6207) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics … Read more

Preclinical Data Presented at the 2025 AACR-NCI-EORTC

Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolism Robust monotherapy activity, as well as combination activity with BBOT’s KRASG12C ON/OFF inhibitor, BBO-8520, and panKRAS inhibitor, BBO-11818, was observed at well-tolerated dose levels in a panel of KRAS-mutant models The combination of a KRAS … Read more

AlphaTON Capital and Cyncado Therapeutics Share New

Dover, DE, Oct. 25, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, today announced that a new poster is live at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. The work, conducted with investigators from the Italian Group … Read more

Kyverna Therapeutics Highlights Potential of KYV-101 in

KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis (RA) KYV-101 continues to demonstrate a well-tolerated profile, consistent with observations from 100 patients treated with KYV-101 to date1 Emerging IIT data in RA reinforce broad potential for KYV-101 in rheumatology indications EMERYVILLE, Calif., Oct. … Read more

Novartis showcases significant immunology advancements in

Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker data informing use of investigational CAR-T cell therapy rapcabtagene autoleucel (YTB323) in systemic lupus erythematosus also to be presented Data underscore Novartis commitment to advance innovative medicines for complex, difficult-to-treat autoimmune diseases with high unmet need Novartis … Read more